Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes
Finding the right provider Who prescribes your GLP-1 matters just as much as whats prescribed
The standard weekly dose ranges from 0.25 mg (starting) to 2.4 mg (maximum maintenance)
GLP-1 and Sulfonylureas Sulfonylureas, like Glipizide and Glyburide, stimulate the pancreas to release more insulin, which can further lower blood sugar and heighten the risk of hypoglycemia when combined with GLP-1 drugs
Curr Top Diabetes
Liraglutide shares 97% sequence homology with human GLP-1 and can bind to and activate GLP-1R.78 The elimination half-life of liraglutide is 13 h, and only one injection per day is required.62 Lixisenatide Lixisenatide was developed by Sanofi to treat T2DM.64,93 Structurally, lixisenatide is based on the exenatide structure but lacks proline at position 38, and six lysines are linked after serine at position 39.94 The six lysine residues increase the rigidity of the molecules structure, thus allowing its drug properties to be improved.78 These changes stabilize its structure, prevent protein degradation of the molecule in the circulation, and increase the circulation time enough to ensure once-daily injection (compared with exenatide, which is injected two or three times daily)